COVID-19 Vaccine Split-Dosing Proves Safe, Noninferior to Conventional Dosing
How does split dosing of COVID-19 vaccines compare with conventional dosing with respect to antibody responsiveness and safety?
ACAAI 2022
Meeting Coverage
Exacerbation Risk Exists for Patients With All Levels of Asthma Control/Severity
In patients using as-needed short-acting beta2-agonists, how are exacerbations associated with asthma control, maintenance adherence, and disease severity?
Use of Biologics Reduces Exacerbations, Emergency Visits in Pediatric Asthma
A real-world study assessed how pediatric patients with moderate to severe asthma responded to the use dupilumab, mepolizumab, and omalizumab.
Azelastine HCl 0.15% Nasal Spray Rapidly Relieves Seasonal Allergy Symptoms
How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis?
Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma
While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma?
Researchers Link Smell Loss, Disease Burden, and Dupilumab Efficacy in CRSwNP
Researchers assessed the link between smell loss in CRSwNP and other disease attributes, as well as the effect of dupilumab according to smell loss severity.
Allergen Exposure, Other Factors Predict Limited Airflow in Pediatric Asthma
What are the most significant predictors of airflow limitation in children 5 to 18 years of age with severe asthma?
Certain Clinical Markers May Predict AERD in Patients With CRSwNP
Which clinical screening markers predict aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis with nasal polyps?
Early Atopic Dermatitis Modifies the Risk for Allergic Respiratory Disease
How does having atopic dermatitis at 2 years of age affect the risk of developing allergic respiratory disease by 10 years of age?
Epicutaneous Immunotherapy Safe, Effective in Toddlers With Peanut Allergy
The phase 3 EPITOPE trial assessed the safety and efficacy of epicutaneous immunotherapy for peanut allergy in children under 4 years old.
COVID-19 Pandemic-Related Changes in HIV Access to Care in San Francisco Area
The COVID-19 pandemic caused people living with HIV to report several changes to their mental health including a decrease in quality of life, increase in anxiety, decrease in feeling connected to friends, decrease in feeling connected to family, and decrease in sleep quality.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in ACAAI 2022
Loading... 
Loading...